<p> Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Research Center, discusses Medicare's recent decision to officially limit Aduhelm (aducanumab) coverage to patients in clinical trials.</p> <p> Read the full article discussed in this interview in the New York Times.</p>

Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Research Center, discusses Medicare's recent decision to officially limit Aduhelm (aducanumab) coverage to patients in clinical trials. Read the full article discussed in this interview in the New York Times.

Medicare Limitation of Aduhelm

The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.

Share Medicare Limitation of Aduhelm

Sign up to save your podcasts

Medicare Limitation of Aduhelm

Medicare Limitation of Aduhelm

More shows like Neurology Minute

JAMA Clinical Reviews

Neurology® Podcast

Practical Neurology Podcast

Mayo Clinic Talks

The Curbsiders Internal Medicine Podcast

Emergency Medical Minute

JAMA Neurology Author Interviews

Neurology Today in 5

Annals On Call Podcast

The Clinical Problem Solvers

Harrison's PodClass: Internal Medicine Cases and Board Prep

Short Wave

Neurology Exam Prep Podcast

The Curious Clinicians

Continuum Audio